Merck Family Fund

Day-to-day investment and grantmaking decisions are led by Executive Director Ruth Goldman and CFO James Maguire, both long-tenured non-family professionals. The board, which includes Merck family descendants Katie Matys (President) and Willy Merck (Vice President), sets overall strategy and approves major commitments. This hybrid structure keeps investment authority with experienced operators while the family retains governance control.

The foundation sources deals primarily through its deep ties to regional philanthropic and impact-investing networks. Ruth Goldman founded the Community Food Funders network, and James Maguire serves on the board of Philanthropy Massachusetts, both of which surface early-stage ventures and community-led projects. The fund also draws on its membership in the Environmental Grantmakers Association for climate and energy pipeline.

It does both. The fund has made direct investments in operating companies like Resonant Energy and Sunwealth, and also commits to pooled vehicles — Acre Venture Partners, an agribusiness fund, is a named participant. The MRI portfolio blends direct equity, fund commitments, and project-level financing, with a tilt toward early-stage and growth-stage ventures.

Both were founded by members of the Merck pharmaceutical family, but they operate as entirely separate entities. The Merck Family Fund, established by George W. Merck in 1954, is a Boston-based grantmaking and impact-investing foundation focused on Massachusetts and New York. The John Merck Fund, named for George's son, was formed later and spent down its endowment in a planned sunset, closing in 2022. They share a family lineage but have never shared governance or staff.

The foundation does not publish a formal exclusion list, but its grantmaking and MRI portfolio indicate a consistent negative screen against fossil fuel extraction, large-scale industrial agriculture, and projects outside the Northeastern United States. Its stated focus is place-based and community-scale — which implicitly excludes global infrastructure, traditional private equity, and sectors without a direct environmental or social-justice nexus.

No. The foundation is capitalized solely by the Merck family's original endowment and does not raise external funds. However, its mission-related investments are frequently syndicated with other impact investors and philanthropic entities — Sunwealth and Resonant Energy both have multiple institutional co-investors — so the fund regularly participates in co-investment structures as a limited partner or direct equity holder alongside aligned institutions.

The foundation walled off its program-related and mission-related investments into a dedicated MRI portfolio that operates alongside — but is accounted for separately from — its traditional grantmaking. Investment returns from the MRI pool are recycled into the endowment. Grantmaking draws on the endowment's annual payout, which is governed by standard 501(c)(3) distribution requirements and directed toward nonprofit partners in Massachusetts and New York.